Afinitor(R) (everolimus) Recommended For Use In The European Union For Patients With Advanced Renal Cell Carcinoma
Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) supporting European Union (EU) approval of everolimus for the treatment of patients with advanced renal cell carcinoma (RCC)3, the most common type of kidney cancer4.
Oncology
Pages: 1 [2]
Interim Study Results Presented At ADA 2009: Exenatide Not Associated With Increased Rate Of Acute Pancreatitis Compared To Other Antidiabetic Drugs
from two national surveys. Int J Clin Pract. 2007;61:737-47. (vi) Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61-78. (vii) Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003;22:331-9. Amylin Pharmaceuticals, IncPages: 1 [2]